219 related articles for article (PubMed ID: 22114792)
1. Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study.
Finocchiaro C; Segre O; Fadda M; Monge T; Scigliano M; Schena M; Tinivella M; Tiozzo E; Catalano MG; Pugliese M; Fortunati N; Aragno M; Muzio G; Maggiora M; Oraldi M; Canuto RA
Br J Nutr; 2012 Jul; 108(2):327-33. PubMed ID: 22114792
[TBL] [Abstract][Full Text] [Related]
2. Effects of n-3 fatty acids and exercise on oxidative stress parameters in type 2 diabetic: a randomized clinical trial.
Fayh APT; Borges K; Cunha GS; Krause M; Rocha R; de Bittencourt PIH; Moreira JCF; Friedman R; da Silva Rossato J; Fernandes JR; Reischak-Oliveira A
J Int Soc Sports Nutr; 2018; 15():18. PubMed ID: 29713249
[TBL] [Abstract][Full Text] [Related]
3. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer.
Murphy RA; Mourtzakis M; Chu QS; Baracos VE; Reiman T; Mazurak VC
Cancer; 2011 Aug; 117(16):3774-80. PubMed ID: 21328326
[TBL] [Abstract][Full Text] [Related]
4. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.
Hoogeveen EK; Geleijnse JM; Kromhout D; Giltay EJ
Eur J Prev Cardiol; 2014 Nov; 21(11):1429-36. PubMed ID: 23774275
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effect of combining fish oil and evening primrose oil supplementation on breast cancer patients undergoing chemotherapy: a randomized placebo-controlled trial.
Arsic A; Krstic P; Paunovic M; Nedovic J; Jakovljevic V; Vucic V
Sci Rep; 2023 Apr; 13(1):6449. PubMed ID: 37081029
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
[TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic impact of omega-3 long chain-polyunsaturated fatty acids on inflammation markers in Duchenne muscular dystrophy: A double-blind, controlled randomized trial.
Rodríguez-Cruz M; Cruz-Guzmán ODR; Almeida-Becerril T; Solís-Serna AD; Atilano-Miguel S; Sánchez-González JR; Barbosa-Cortés L; Ruíz-Cruz ED; Huicochea JC; Cárdenas-Conejo A; Escobar-Cedillo RE; Yam-Ontiveros CA; Ricárdez-Marcial EF
Clin Nutr; 2018 Dec; 37(6 Pt A):1840-1851. PubMed ID: 28987470
[TBL] [Abstract][Full Text] [Related]
8. Effects of omega-3 fatty acid plus alpha-tocopherol supplementation on malnutrition-inflammation score, biomarkers of inflammation and oxidative stress in chronic hemodialysis patients.
Asemi Z; Soleimani A; Shakeri H; Mazroii N; Esmaillzadeh A
Int Urol Nephrol; 2016 Nov; 48(11):1887-1895. PubMed ID: 27554670
[TBL] [Abstract][Full Text] [Related]
9. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
10. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.
Cerchietti LC; Navigante AH; Castro MA
Nutr Cancer; 2007; 59(1):14-20. PubMed ID: 17927497
[TBL] [Abstract][Full Text] [Related]
11. Effect of eicosapentaenoic and docosahexaenoic acid on resting and exercise-induced inflammatory and oxidative stress biomarkers: a randomized, placebo controlled, cross-over study.
Bloomer RJ; Larson DE; Fisher-Wellman KH; Galpin AJ; Schilling BK
Lipids Health Dis; 2009 Aug; 8():36. PubMed ID: 19691834
[TBL] [Abstract][Full Text] [Related]
12. Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment.
van der Meij BS; Langius JA; Smit EF; Spreeuwenberg MD; von Blomberg BM; Heijboer AC; Paul MA; van Leeuwen PA
J Nutr; 2010 Oct; 140(10):1774-80. PubMed ID: 20739445
[TBL] [Abstract][Full Text] [Related]
13. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H
Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375
[TBL] [Abstract][Full Text] [Related]
14. Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial.
Wu YL; Lee JS; Thongprasert S; Yu CJ; Zhang L; Ladrera G; Srimuninnimit V; Sriuranpong V; Sandoval-Tan J; Zhu Y; Liao M; Zhou C; Pan H; Lee V; Chen YM; Sun Y; Margono B; Fuerte F; Chang GC; Seetalarom K; Wang J; Cheng A; Syahruddin E; Qian X; Ho J; Kurnianda J; Liu HE; Jin K; Truman M; Bara I; Mok T
Lancet Oncol; 2013 Jul; 14(8):777-86. PubMed ID: 23782814
[TBL] [Abstract][Full Text] [Related]
15. EPA+DHA, but not ALA, Improved Lipids and Inflammation Status in Hypercholesterolemic Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
Zhou Q; Zhang Z; Wang P; Zhang B; Chen C; Zhang C; Su Y
Mol Nutr Food Res; 2019 May; 63(10):e1801157. PubMed ID: 30900815
[TBL] [Abstract][Full Text] [Related]
16. Impact of omega-3 fatty acid oral therapy on healing of chronic venous leg ulcers in older adults: Study protocol for a randomized controlled single-center trial.
McDaniel JC; Rausch J; Tan A
Trials; 2020 Jan; 21(1):93. PubMed ID: 31948466
[TBL] [Abstract][Full Text] [Related]
17. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
[TBL] [Abstract][Full Text] [Related]
18. Fish oil supplementation does not lower C-reactive protein or interleukin-6 levels in healthy adults.
Muldoon MF; Laderian B; Kuan DC; Sereika SM; Marsland AL; Manuck SB
J Intern Med; 2016 Jan; 279(1):98-109. PubMed ID: 26497831
[TBL] [Abstract][Full Text] [Related]
19. Healthy effect of different proportions of marine ω-3 PUFAs EPA and DHA supplementation in Wistar rats: Lipidomic biomarkers of oxidative stress and inflammation.
Dasilva G; Pazos M; García-Egido E; Gallardo JM; Rodríguez I; Cela R; Medina I
J Nutr Biochem; 2015 Nov; 26(11):1385-92. PubMed ID: 26320676
[TBL] [Abstract][Full Text] [Related]
20. The differential effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on seizure frequency in patients with drug-resistant epilepsy - A randomized, double-blind, placebo-controlled trial.
Ibrahim FAS; Ghebremeskel K; Abdel-Rahman ME; Ahmed AAM; Mohmed IM; Osman G; Elseed M; Hamed A; Rabinowicz AL; Salih MAM; Elbashir MI; Daak AA
Epilepsy Behav; 2018 Oct; 87():32-38. PubMed ID: 30170260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
